Applied Dna Sciences Inc [NASDAQ: APDN] stock went on a downward path that fall over -4.06% on Thursday, amounting to a one-week price decrease of less than -8.92%.
Over the last 12 months, APDN stock dropped by -99.05%. The one-year Applied Dna Sciences Inc stock forecast points to a potential upside of 89.33. The average equity rating for APDN stock is currently 3.00, trading closer to a bullish pattern in the stock market.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for the stock reached $7.99 million, with 50.48 million shares outstanding and 50.41 million shares in the current float. Compared to the average trading volume of 6.82M shares, APDN stock reached a trading volume of 3677099 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Applied Dna Sciences Inc [APDN]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for APDN shares is $1.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on APDN stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
ROTH Capital have made an estimate for Applied Dna Sciences Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on February 12, 2021. While these analysts kept the previous recommendation, H.C. Wainwright dropped their target price from $18 to $14. The new note on the price target was released on January 14, 2021, representing the official price target for Applied Dna Sciences Inc stock. Previously, the target price had yet another drop from $20 to $12, while H.C. Wainwright kept a Buy rating on APDN stock. On July 20, 2020, analysts increased their price target for APDN shares from 18 to 22.
The Average True Range (ATR) for Applied Dna Sciences Inc is set at 0.04, with the Price to Sales ratio for APDN stock in the period of the last 12 months amounting to 2.35. The Price to Book ratio for the last quarter was 0.13, with the Price to Cash per share for the same quarter was set at 0.21.
APDN Stock Performance Analysis:
Applied Dna Sciences Inc [APDN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -8.92. With this latest performance, APDN shares dropped by -54.52% in over the last four-week period, additionally sinking by -92.20% over the last 6 months – not to mention a drop of -99.05% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for APDN stock in for the last two-week period is set at 28.33, with the RSI for the last a single of trading hit 24.04, and the three-weeks RSI is set at 33.23 for Applied Dna Sciences Inc [APDN]. The present Moving Average for the last 50 days of trading for this stock 0.4721, while it was recorded at 0.1641 for the last single week of trading, and 3.3303 for the last 200 days.
Insight into Applied Dna Sciences Inc Fundamentals:
Applied Dna Sciences Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.76 and a Current Ratio set at 3.91.
APDN Stock EPS
With the latest financial reports released by the company, Applied Dna Sciences Inc posted -6.1/share EPS, while the average EPS was predicted by analysts to be reported at -5.3/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -0.8. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for APDN.
Applied Dna Sciences Inc [APDN] Institutonal Ownership Details
There are presently around $0.50%, or 0.50%% of APDN stock, in the hands of institutional investors.
